ArticleMetabolites2026

Exploratory Analysis of Gut Microbiome and Metabolic Profile Changes Following Lenvatinib and Anti-PD-1 Combination Therapy in Liver Cancer.

Rui Zhong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.